TU Dresden

100 000 babies screened for increased type 1 diabetes risk in Freder1k Study
Researchers from Dresden contribute to international success [read more]
Arthur is screening participant 100,000 © CRTD
TU Dresden retains its title as University of Excellence
Everybody at our university is excited: TU Dresden has received permanent funding as a University of Excellence! [read more]
© Amac Garbe
Summer University at CRTD
Stem cells & sensory organs - this was the motto... [read more]
13th CRTD Summer Conference offered great scientific exchange
180 scientists and company representatives assembled on June 28, 2019 [read more]
Summer Conference © CRTD
The POInT study is growing
More than a year ago, the Freder1k study was expanded to include the "POInT study: Primary Oral Insulin Trial". [read more]
State Secretary Uwe Gaul opened the 1st POInT Summer Party at the CRTD © Kathleen Biermann-Jung
Widespread disease diabetes: Why do beta cells refuse to release insulin?
New insights into the "teamwork" of cells: Super-connected "leader" cells coordinate insulin response and help us to understand how diabetes develops One in eleven adults... [read more]
Cover of Nature Metabolism, June 2019
Rise and shine to science
CRTD, B CUBE and BIOTEC welcomed more than 2,000 visitors to the 17th Dresden Science Night [read more]
Dresden Science Night © Friederike Braun
CRTD researchers bring innovation from bench to bedside
Novel process for the production of suppressive T cells The Center for Regenerative Therapies (CRTD) at the TU Dresden and the University Hospital Carl Gustav Carus have successfully... [read more]
The Good Manufacturing Practice (GMP) Facility of the CRTD © CRTD

Research at the Center for Regenerative Therapies (CRTD) at TU Dresden focuses on discovering principles of cell and tissue regeneration, and leveraging this for recognition, treatment, and reversal of diseases. The CRTD is well positioned for this challenge with its diversity in model organisms, organs, and disease systems and its range of methodological approaches from basic research to validation projects and clinical studies. The CRTD links the bench to the clinic, and scientists to clinicians to bring expertise in stem cells, gene-editing, and regeneration towards innovative therapies for metabolic, osteo-hematological, and neurological diseases.